abstract |
A cruciferous vegetable (Brassicaceae) having a glucosinolate and / or at least one derivative thereof in an amount of 20 to 100 μmol / g dry weight for use in the treatment of cardiovascular disease (CVD) or for use in promotion of cardiac and / or cardiovascular health in a human subject, in which at least one derivative thereof is selected from at least one of: 4-methylsulfinylbutyl glucosinolate, 3-methylsulfinylpropyl glucosinolate, 4-methylthiobutyl glucosinolate, 3-methylthiopropyl glucosinolate, sulforaphane , erucina, sativina, iberina, β-phenylethylisothiocyanate (PE-ITC), 3-methylthiopropyl isothiocyanate in which the cruciferous vegetable (Brassicaceae) is broccoli and these subjects are defined as those whose risk of CVD at 10 years is 10% at twenty%. |